| 1EPW | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B |
| 1F31 | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE |
| 1F82 | A: | BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN |
| 1G9A | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3) |
| 1G9B | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1) |
| 1G9C | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4) |
| 1G9D | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2) |
| 1I1E | A:1-533 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN |
| 1S0B | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0 |
| 1S0C | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 |
| 1S0D | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 |
| 1S0E | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 |
| 1S0F | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0 |
| 1S0G | A:1-533 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM |
| 2ETF | A:; B: | CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN |
| 2NP0 | A:1-533 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN |
)
)